Gene Therapy Accounts For A Major Portion Of The Cell And Gene Therapy Market And It Is Expected To Have The Most Growth

By Globe Newswire9 days ago

LONDON, Feb. 23, 2021 (GLOBE NEWSWIRE) -- New year, new updates! Our reports have been revised for market size, forecasts, and strategies to take on 2021 after the COVID-19 impact: https://www.thebusinessresearchcompany.com/global-market-reports

According to The Business Research Company's research report on the cell and gene therapy market, the gene therapy market was the largest segment of the cell and gene therapy market segmented by product, accounting for 72.4% of the total in 2020. Going forward, the gene therapy segment is expected to be the fastest growing segment by product, at a CAGR of 30.8% during 2020-2025.

Thus, the top opportunities in the gene cell therapy industry segmented by-product will arise in the gene therapy segment, which will gain $8.97 billion of global annual sales by 2025. The top opportunities in the cell and gene therapy market segmented by the application will arise in the oncology segment, which will gain $6.73 billion of global annual sales by 2025. The cell and gene therapy market size will gain the most in the USA at $3.36 billion.

Genes are the basic physical and functional unit of heredity, received from one's parents. Genes act as a code for the creation of all proteins in a living organism. Gene therapy seeks to manipulate a patient's cells to alter the biological property of cells for the treatment of an inherited or acquired disease. It works by several mechanisms, including replacing a disease-causing gene with a healthy copy of the gene, inactivating an ill-functioning disease-causing gene, or introducing a modified gene into the body to treat diseases. On the other hand, cell therapy seeks to treat diseases ...

Full story available on Benzinga.com

Continue read on benzinga.com